Browsing by Author Nikolaidou, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 9 of 9
TitleAuthor(s)Issue date???itemlist.???
Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabinePappas, P.; Mavroudis, D.; Nikolaidou, M.; Georgoulias, V.; Marselos, M.24-Nov-2015-
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursBozionelou, V.; Vamvakas, L.; Pappas, P.; Agelaki, S.; Androulakis, N.; Kalykaki, A.; Nikolaidou, M.; Kentepozidis, N.; Giassas, S.; Marselos, M.; Georgoulias, V.; Mavroudis, D.24-Nov-2015-
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumorsKalbakis, K.; Pappas, P.; Kouroussis, C.; Vamvakas, L.; Kalykaki, A.; Vardakis, N.; Nikolaidou, M.; Marselos, M.; Georgoulias, V.; Mavroudis, D.24-Nov-2015-
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumorsSaridaki, Z.; Pappas, P.; Souglakos, J.; Nikolaidou, M.; Vardakis, N.; Kotsakis, A.; Marselos, M.; Georgoulias, V.; Mavroudis, D.24-Nov-2015-
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMavroudis, D.; Pappas, P.; Kouroussis, C.; Kakolyris, S.; Agelaki, S.; Kalbakis, K.; Androulakis, N.; Souglakos, J.; Vardakis, N.; Nikolaidou, M.; Samonis, G.; Marselos, M.; Georgoulias, V.24-Nov-2015-
Metronomic oral vinorelbine (MOVIN): a dose establishing translational and pharmacokinetic study in patients with metastatic refractory cancerBriasoulis, E.; Tolis, C.; Pappas, P.; Marselos, M.; Nicolaides, C.; Nikiforidis, L.; Nikolaidou, M.; Siarabi, O.; Tzamakou, E.; Pavlidis, N.24-Nov-2015-
Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinomaFroudarakis, M. E.; Pataka, A.; Pappas, P.; Anevlavis, S.; Argiana, E.; Nikolaidou, M.; Kouliatis, G.; Pozova, S.; Marselos, M.; Bouros, D.24-Nov-2015-
A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancerFountzilas, G.; Fragkoulidi, A.; Kalogera-Fountzila, A.; Nikolaidou, M.; Bobos, M.; Calderaro, J.; Andreiuolo, F.; Marselos, M.24-Nov-2015-
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapyPentheroudakis, G.; Pappas, P.; Golfinopoulos, V.; Fountzilas, G.; Nikolaidou, M.; Boumba, V. A.; Vougiouklakis, T.; Nikiforidis, L.; Tzamakou, E.; Siarabi, O.; Marselos, M.; Pavlidis, N.24-Nov-2015-